Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Schäffler

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Oncology Research and Treatment|June 26, 2023
Curative Polyendocrine Therapy in a 21-year-Old Patient with Endometrial Carcinoma: Case Report and Review of the LiteratureHenning Schäffler, Moritz Dimpfl, Fabienne Schochter, et al.
Deutsches Arzteblatt International|April 28, 2022
Extragenital Endometriosis in the Differential Diagnosis of Non- Gynecological DiseasesStefan Lukac, Marinus Schmid, Kerstin Pfister, et al.
Journal of Multidisciplinary Healthcare|June 9, 2026
Training and Subjective Confidence in CTG Interpretation in Germany: A National Cross-Sectional SurveyHenning Schäffler, Moritz Dimpfl, Beate Hüner, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 5, 2023
Three-dimensional model for improvement of endometriosis care (3D-E)Stefan Lukac, Katharina Hancke, Wolfgang Janni, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 21, 2026
Physiological cardiotocography interpretation and neonatal morbidity: A historical pre-post cohort study in a tertiary perinatal centerSophia Andres, Henning Schäffler, Kay Stankov, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib - Which One, How and For Whom?Stefan Lukac, Kerstin Pfister, Henning Schäffler, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
Correction: Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib - Which One, How and For Whom?Stefan Lukac, Kerstin Pfister, Henning Schäffler, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 3, 2024
Eco-logistical comparison of non-radioactive seeds and the wire-guided localization for intraoperative detection of breast lesionsStefan Lukac, Elena Leinert, Thorsten Kühn, et al.
Journal of Cell Science|May 12, 2019
The cancer-associated meprin β variant G32R provides an additional activation site and promotes cancer cell invasionHenning Schäffler, Wenjia Li, Ole Helm, et al.
Breast Care (Basel, Switzerland)|May 7, 2025
Do We Need Anthracyclines for Elderly Patients with Triple-Negative Breast Cancer?Stefan Lukac, Visnja Fink, Thomas W P Friedl, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Oncology Research and Treatment|June 26, 2023
Curative Polyendocrine Therapy in a 21-year-Old Patient with Endometrial Carcinoma: Case Report and Review of the LiteratureHenning Schäffler, Moritz Dimpfl, Fabienne Schochter, et al.
Deutsches Arzteblatt International|April 28, 2022
Extragenital Endometriosis in the Differential Diagnosis of Non- Gynecological DiseasesStefan Lukac, Marinus Schmid, Kerstin Pfister, et al.
Journal of Multidisciplinary Healthcare|June 9, 2026
Training and Subjective Confidence in CTG Interpretation in Germany: A National Cross-Sectional SurveyHenning Schäffler, Moritz Dimpfl, Beate Hüner, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 5, 2023
Three-dimensional model for improvement of endometriosis care (3D-E)Stefan Lukac, Katharina Hancke, Wolfgang Janni, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 21, 2026
Physiological cardiotocography interpretation and neonatal morbidity: A historical pre-post cohort study in a tertiary perinatal centerSophia Andres, Henning Schäffler, Kay Stankov, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib - Which One, How and For Whom?Stefan Lukac, Kerstin Pfister, Henning Schäffler, et al.
Geburtshilfe Und Frauenheilkunde|June 13, 2025
Correction: Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib - Which One, How and For Whom?Stefan Lukac, Kerstin Pfister, Henning Schäffler, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 3, 2024
Eco-logistical comparison of non-radioactive seeds and the wire-guided localization for intraoperative detection of breast lesionsStefan Lukac, Elena Leinert, Thorsten Kühn, et al.
Journal of Cell Science|May 12, 2019
The cancer-associated meprin β variant G32R provides an additional activation site and promotes cancer cell invasionHenning Schäffler, Wenjia Li, Ole Helm, et al.
Breast Care (Basel, Switzerland)|May 7, 2025
Do We Need Anthracyclines for Elderly Patients with Triple-Negative Breast Cancer?Stefan Lukac, Visnja Fink, Thomas W P Friedl, et al.
Pageof 3